Guided Therapeutics (GTHP) Other Operating Expenses (2010 - 2025)

Guided Therapeutics has disclosed Other Operating Expenses across 16 years of filings, most recently posting $23000.0 for Q4 2025.

• Other Operating Expenses for Q4 2025 came in at $23000.0, down 66.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $169000.0 (down 41.11% YoY), and the FY2025 annual result was $169000.0, down 41.11% from the prior year.
• Other Operating Expenses came in at $23000.0 for Q4 2025 at Guided Therapeutics, up from $22000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $76000.0 in Q3 2024 to a low of -$1000.0 in Q2 2022.
• The 5-year median for Other Operating Expenses is $52000.0 (2022), against an average of $50250.0.
• Across the five-year window, Other Operating Expenses plunged 103.7% in 2022 and surged 6200.0% in 2023, its largest moves.
• Guided Therapeutics' Other Operating Expenses stood at $34000.0 in 2021, then jumped by 52.94% to $52000.0 in 2022, then gained by 25.0% to $65000.0 in 2023, then grew by 6.15% to $69000.0 in 2024, then slumped by 66.67% to $23000.0 in 2025.
• The last three Other Operating Expenses figures came in at $23000.0 (Q4 2025), $22000.0 (Q3 2025), and $51000.0 (Q2 2025), per Business Quant data.